Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
2.
Can Urol Assoc J ; 6(4): E137-9, 2012 Aug.
Article in English | MEDLINE | ID: mdl-23093564

ABSTRACT

Chronic granulomatous inflammation may develop after injecting foreign oily substances into the penis. The disorder affects mainly the site of administration, but regional lymphadenopathy or even systemic disease can occur. We present a 39-year-old man with petroleum jelly-induced penile lesion and unilateral inguinal lymphadenitis mimicking incarcerated inguinal hernia. At hernioplasty no hernial sac was found, but enlarged lymph nodes suspicious for malignancy were identified. The histopathologic findings of these nodes were consistent with mineral oil granuloma. Paraffinoma of the male genitalia can cause various clinical features posing a differential diagnostic dilemma. Regional lymphadenitis may be the main clinical characteristic. Patient's history, physical and histopathological examination are required to establish the diagnosis.

3.
Biochim Biophys Acta ; 1820(10): 1512-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22683700

ABSTRACT

BACKGROUND: Galectins are potent immune regulators, with galectin-8 acting as a pro-apoptotic effector on synovial fluid cells and thymocytes and stimulator on T-cells. To set a proof-of-principle example for risk assessment in autoimmunity, and for a mutation affecting physiological galectin sensor functions, a polymorphism in the coding region of the galectin-8 gene (rs2737713; F19Y) was studied for its association with two autoimmune disorders, i.e. rheumatoid arthritis and myasthenia gravis. METHODS: A case-control analysis and a related quantitative trait-association study were performed to investigate the association of this polymorphism in patients (myasthenia gravis 149, rheumatoid arthritis 214 and 134 as primary and repetitive cohorts, respectively) and 365 ethnically matched (Caucasian) healthy controls. Distribution was also investigated in patients grouped according to their antibody status and age at disease onset. Comparative testing for lectin activity was carried out in ELISA/ELLA-based binding tests with both wild-type and F19Y mutant galectin-8 from peripheral blood mononuclear cell lysates of healthy individuals with different genotypes as well as with recombinant wild-type and F19Y mutant galectin-8 proteins. RESULTS: A strong association was found for rheumatoid arthritis, and a mild one with myasthenia gravis. Furthermore, the presence of the sequence deviation also correlated with age at disease onset in the case of rheumatoid arthritis. The F19Y substitution did not appear to affect carbohydrate binding in solid-phase assays markedly. GENERAL SIGNIFICANCE: This is the first report of an association between a galectin-based polymorphism leading to a mutant protein and autoimmune diseases, with evidence for antagonistic pleiotropy.


Subject(s)
Autoimmune Diseases/genetics , Galectins/genetics , Immunologic Factors/genetics , Polymorphism, Single Nucleotide , White People/genetics , Adolescent , Adult , Aged , Amino Acid Substitution/genetics , Autoimmune Diseases/epidemiology , Autoimmune Diseases/ethnology , Case-Control Studies , Female , Galectins/physiology , Genetic Association Studies , Genetics, Population , Humans , Immunologic Factors/physiology , Male , Middle Aged , Mutation, Missense/physiology , Phenylalanine/genetics , Polymorphism, Single Nucleotide/physiology , Tyrosine/genetics , White People/statistics & numerical data , Young Adult
4.
Magy Seb ; 65(3): 83-91, 2012 Jun.
Article in Hungarian | MEDLINE | ID: mdl-22717961

ABSTRACT

BACKGROUND: Surgical Site Infection (SSI) is the third most frequent nosocomial infection, and accounts for 14-16% of all infections. While the treatment of SSI can be very costly, previous results indicated that triclosan may reduce SSI rate. Therefore, we carried out a prospective randomised trial to further evaluate the effect of triclosan after elective colorectal surgery. METHODS: Seven surgical units in Hungary were involved in a prospective, randomised, multicentric clinical trial to compare triclosan coated (PDS plus®) and uncoated (PDS II®) sutures for abdominal wall closure in elective colorectal surgery. Pre- and perioperative variables were recorded in an online database. The primary aims of the study were to determine the incidence of SSI and the pathogens associated with it, as well as evaluation of additional cost of treatment. RESULTS: 485 patients were randomised. SSI occurred in 47 cases (12.5%), of those 23 (12.23%) from the triclosan group (n = 188) and 24 (12.18%) from the uncoated group (n = 197, p = 0.982). In 13 (27.66%) cases late appearance of SSI was detected, of those 4 patients with triclosan coated suture (8.51%) and 9 patients with uncoated suture (19.15%, p = 0.041). There was no difference between the type of incisions or elective colon and rectal resections in terms of incidence of SSI. CONCLUSION: Beneficial effect of triclosan against Gram positive bacteria could not be confirmed in our study due to the relatively low number of patients with SSI. Furthermore, triclosan did not influence the incidence of SSI due to Gram negative bacteria. SSI rate decreased by 50% compared to our previous study, however, it was regardless of the use of coated or uncoated PDS loop. Finally, operative factors were more important than patient's risk factors in terms of incidence of SSI. In case SSI developed, delayed discharge from hospital as well as special wound care significantly increased overall cost of treatment.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Colonic Diseases/surgery , Colorectal Surgery/methods , Rectal Diseases/surgery , Surgical Wound Infection/epidemiology , Sutures , Triclosan/therapeutic use , Aged , Female , Humans , Hungary/epidemiology , Incidence , Male , Middle Aged , Prospective Studies , Surgical Wound Infection/etiology , Treatment Outcome
5.
Magy Seb ; 63(6): 384-6, 2010 Dec.
Article in Hungarian | MEDLINE | ID: mdl-21147673

ABSTRACT

The incidence of fungal infections such as Aspergillosis is increasing among immunocompromised patients. Demand for diagnosis of mycotic diseases is steadily raising among clinicians and treatment of these patients represents a continually growing challenge. The authors present a case of a 53-year-old male patient with Aspergillus peritonitis. This case deserves attention because its extreme rarity in the medical literature and complex therapy of coinfections during the hospital stay which was difficult and relatively expensive. The importance of consultation and microbiological sampling is emphasized.


Subject(s)
Amphotericin B/therapeutic use , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis , Immunocompromised Host , Peritonitis , Aspergillosis/complications , Aspergillosis/diagnosis , Aspergillosis/drug therapy , Clindamycin/therapeutic use , Cross Infection/complications , Cross Infection/diagnosis , Cross Infection/drug therapy , Cross Infection/microbiology , Humans , Male , Meropenem , Middle Aged , Peritonitis/complications , Peritonitis/drug therapy , Peritonitis/microbiology , Subphrenic Abscess/complications , Subphrenic Abscess/diagnosis , Subphrenic Abscess/drug therapy , Subphrenic Abscess/microbiology , Thienamycins/therapeutic use
6.
Orv Hetil ; 150(48): 2182-8, 2009 Nov 29.
Article in Hungarian | MEDLINE | ID: mdl-19923097

ABSTRACT

Small breast cancers often require different treatment than larger ones. The frequency and predictability of further nodal involvement was evaluated in patients with positive sentinel lymph nodes and breast cancers < or =15 mm by means of 8 different predictive tools. Of 506 patients with such small tumors 138 with positive sentinel nodes underwent axillary dissection and 39 of these had non-sentinel node involvement too. The Stanford nomogram and the micrometastatic nomogram were the predictive tools identifying a small group of patients with low probability of further axillary involvement that might not require completion axillary lymph node dissection. Our data also suggest that the Tenon score can separate subsets of patients with a low and a higher risk of non-sentinel node metastasis. Predictive tools based on multivariate models can help in omitting completion axillary dissection in patients with low risk of non-sentinel lymph node metastasis based on their small tumor size.


Subject(s)
Breast Neoplasms/pathology , Lymph Nodes/pathology , Nomograms , Sentinel Lymph Node Biopsy , Adult , Aged , Axilla , Female , Humans , Logistic Models , Lymphatic Metastasis , Middle Aged , Multivariate Analysis , Neoplasm Invasiveness , Predictive Value of Tests
7.
Pathol Oncol Res ; 15(4): 733-40, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19440855

ABSTRACT

Several models have previously been proposed to predict the probability of non-sentinel lymph node (NSLN) metastases after a positive sentinel lymph node (SLN) biopsy in breast cancer. The aim of this study was to assess the accuracy of two previously published nomograms (MSKCC, Stanford) and to develop an alternative model with the best predictive accuracy in a Czech population. In the basic population of 330 SLN-positive patients from the Czech Republic, the accuracy of the MSKCC and the Stanford nomograms was tested by the area under the receiver operating characteristics curve (AUC). A new model (MOU nomogram) was proposed according to the results of multivariate analysis of relevant clinicopathologic variables. The new model was validated in an independent test population from Hungary (383 patients). In the basic population, six of 27 patients with isolated tumor cells (ITC) in the SLN harbored additional NSLN metastases. The AUCs of the MSKCC and Stanford nomograms were 0.68 and 0.66, respectively; for the MOU nomogram it reached 0.76. In the test population, the AUC of the MOU nomogram was similar to that of the basic population (0.74). The presence of only ITC in SLN does not preclude further nodal involvement. Additional variables are beneficial when considering the probability of NSLN metastases. In the basic population, the previously published nomograms (MSKCC and Stanford) showed only limited accuracy. The developed MOU nomogram proved more suitable for the basic population, such as for another independent population from a mid-European country.


Subject(s)
Breast Neoplasms/pathology , Lymphatic Metastasis/diagnosis , Nomograms , Sentinel Lymph Node Biopsy , Adult , Aged , Aged, 80 and over , Algorithms , Breast Neoplasms/ethnology , Czech Republic , Female , Humans , Lymphatic Metastasis/pathology , Middle Aged , Predictive Value of Tests , ROC Curve
8.
Pathol Oncol Res ; 15(3): 527-32, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19172413

ABSTRACT

Colorectal carcinomas (CRCs) infiltrating through the muscularis propria layer without infiltration of adjacent structures, organs or the serosa-i.e. the pT3 tumors, compose the largest subset of large intestinal carcinomas treated by surgical resection. They are heterogeneous in terms of prognosis. CRCs treated by surgery in a period of 69 months were prospectively classified as pT3a tumors (invading to a maximum of 5 mm beyond the muscularis propria) and pT3b tumors (invading deeper). Their nodal status, incidence of vascular invasion and the presence or absence of distant metastases were analyzed in relation to the depth of invasion. Of the 593 CRCs primarily treated by surgery 429 were pT3 tumors. CRCs categorized as pT3a had significantly lower rates of nodal involvement (44% vs 75%), massive nodal involvement (pN2) (9% vs 39%), venous invasion (17% vs 30%) and distant metastasis (11% vs 28%) than pT3b tumors. Significant differences in these prognostic variables in pT3a and pT3b cancers were observed both for carcinomas of the colon and those of the rectum. Such differences were not obvious in further 66 ypT3 cases of rectal carcinoma receiving neoadjuvant treatment before surgery. Tumors in the pT3a category are associated with a better prognostic profile than pT3b tumors. This subdivision might be useful in both prognostication and treatment planning.


Subject(s)
Adenocarcinoma/pathology , Colorectal Neoplasms/pathology , Neoplasm Metastasis/pathology , Adenocarcinoma/therapy , Aged , Antineoplastic Agents , Colorectal Neoplasms/therapy , Combined Modality Therapy , Female , Humans , Male , Neoadjuvant Therapy , Neoplasm Staging , Prognosis , Radiotherapy
9.
J Surg Oncol ; 95(8): 629-34, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17492634

ABSTRACT

BACKGROUND AND OBJECTIVES: Successful sentinel lymph node (SLN) biopsy has been reported in colorectal cancer (CRC), but its results are still controversial. The SLN theory suggests that there is an orderly spread from the primary tumor to the SLNs first, and from the SLNs to further nodes later. This study examines the influence of nodal metastasis size on further nodal involvement. METHODS: CRC resection specimens with nodal metastasis have been evaluated for the maximum nodal metastasis size for a period of 5 years. All lymph nodes (LNs) were submitted to standard histological examination. RESULTS: Two hundred thirty-five CRC specimens with a single invasive tumor were assessed. The mean numbers of LNs examined and involved were 18 and 4, respectively. The largest metastasis size ranged from 0.14 to 22.1 mm. There was a significant correlation between this parameter and the number or the ratio of LNs involved (Spearman's Rho: 0.517, and 0.382, respectively; P < 0.0001). A cluster analysis identified three relatively distinct groups of low, intermediate, and extensive nodal involvement. CONCLUSIONS: The correlation of the largest metastasis size with the number and the ratio of involved nodes may be an indirect proof of the sequential spread from first echelon LNs to further nodes. However, the data suggest a more complex process: with increasing metastasis size, the number of involved nodes and its variability increase more than might be expected. This suggests a recruitment or cascade process, which becomes more unpredictable as nodal tumor burden increases.


Subject(s)
Colorectal Neoplasms/pathology , Intestine, Large/pathology , Lymph Nodes/pathology , Sentinel Lymph Node Biopsy , Tumor Burden , Aged , Colorectal Neoplasms/surgery , Female , Humans , Lymph Node Excision , Lymphatic Metastasis , Male , Middle Aged
10.
Magy Seb ; 59(3): 164-72, 2006 Jun.
Article in Hungarian | MEDLINE | ID: mdl-16937791

ABSTRACT

UNLABELLED: Sentinel node biopsy (SNB) is controversial for in situ breast cancers. We reviewed our experience with in situ and microinvasive carcinomas and surveyed the literature. METHODS: SNB was performed with intraparenchymal administration of vital dye alone or combined with radiocolloid. The SNs were assessed histologically with haematoxylin eosin staining and cytokeratin immunohistochemistry. RESULTS: Patients with in situ (36) or microinvasive (20) carcinomas underwent SNB: 59 axillary and 1 parasternal, and 39 axillary and 1 parasternal SNs were recovered, respectively. The SNs were positive in 4 patients and 1 patient, respectively: 1 micrometastasis and 3 isolated tumour cells, and 1 micrometastasis in the respective groups. No further axillary nodes were found positive after dissection. Further 21 invasive carcinomas (often with extensive intraductal component) had an in situ carcinoma diagnosis preoperatively: of 39 axillary and 3 parasternal SNs 10 patients had nodal involvement in 13 axillary SNs; 5 patients also had further lymph nodes involved after dissection. CONCLUSIONS: The definitive diagnosis of in situ carcinoma does not warrant SNB. This procedure should be considered if the tumour is to be removed by mastectomy, or if the diagnosis is preoperative and there are associated high-risk factors for the subsequent diagnosis of invasive cancer.


Subject(s)
Breast Neoplasms/surgery , Carcinoma in Situ/surgery , Carcinoma, Ductal, Breast/surgery , Lymph Nodes/pathology , Sentinel Lymph Node Biopsy , Adult , Aged , Breast Neoplasms/pathology , Carcinoma in Situ/pathology , Carcinoma, Ductal, Breast/pathology , Contrast Media/administration & dosage , Female , Hospitals, County , Humans , Hungary , Immunohistochemistry , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis/diagnosis , Middle Aged , Radionuclide Imaging , Radiopharmaceuticals , Retrospective Studies , Sentinel Lymph Node Biopsy/methods , Technetium Tc 99m Aggregated Albumin
11.
Magy Seb ; 58(4): 225-32, 2005 Aug.
Article in Hungarian | MEDLINE | ID: mdl-16261868

ABSTRACT

INTRODUCTION: The neoadjuvant chemotherapy is increasingly being used in the treatment of patients with locally advanced breast cancer. We describe the hypothesis of the biological behaviour of breast cancer supporting the reason for the existence of this treatment. The improvement of neoadjuvant chemotherapy is being discussed as well as the advantages, disadvantages and problems of the treatment. THE AIM OF EXAMINATION: To study the results of neoadjuvant chemotherapy in patients with locally advanced breast cancer and the proportion of breast preserving surgery after the treatment. METHODS: Sixty seven patients were given neoadjuvant chemotherapy treatment between 01.01.1999 and 12.31.2003. Twenty three patients were stage III A while 35 stage III B and 9 stage III C. 63% of the patients received CEF chemotherapy and 19% were given MMM. 18% were given neoadjuvant Taxotere + Carboplatin and 4% were given Taxotere + Farmorubicin chemotherapy. RESULTS: After neoadjuvant chemotherapy 5 patients had SD (stable disease), 32 patients had MR (minor response) and in 28 cases patients had PR (partial response). Two patients showed pCR (complete pathologic response). Twenty patients (30%) had breast preserving surgery. CONCLUSIONS: On the basis of our own experience neoadjuvant therapy is justified in patients with locally advanced breast cancer as they have bigger chance for breast preserving surgery. If mastectomy and axillary block dissection has to be carried out they are easier to perform. Taxans must be introduced for neoadjuvant treatment in order to improve our results. A longer follow-up is necessary before drawing final conclusions.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Mastectomy, Segmental , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/drug therapy , Breast Neoplasms/surgery , Carboplatin/administration & dosage , Chemotherapy, Adjuvant , Cyclophosphamide/administration & dosage , Cytarabine/administration & dosage , Docetaxel , Epirubicin/administration & dosage , Female , Humans , Middle Aged , Neoadjuvant Therapy/methods , Neoplasm Staging , Retrospective Studies , Taxoids/administration & dosage , Treatment Outcome
12.
Magy Seb ; 58(2): 80-3, 2005 Apr.
Article in Hungarian | MEDLINE | ID: mdl-16018272

ABSTRACT

We performed splenectomy combined with spleen autotransplantation after blunt abdominal trauma by minimally invasive technique at the County Teaching Hospital in Kecskemét. In case of advanced post traumatic spleen injury, spleen autotransplantation (Furka's spleen chips) is a well-known method to try to avoid postsplenectomy syndrome. During the operation, when in situ preservation of the spleen is not possible, chips of spleen tissue are transplanted into the omentum. Function of the transplanted spleen tissue was monitored by scintigraphy. We describe two different types of spleen scintigraphy to check the viability of spleen chips.


Subject(s)
Laparoscopy , Monitoring, Physiologic , Postoperative Care , Spleen/diagnostic imaging , Spleen/surgery , Splenectomy/methods , Humans , Male , Middle Aged , Monitoring, Physiologic/methods , Postoperative Care/methods , Radionuclide Imaging , Spleen/transplantation , Transplantation, Autologous
13.
Magy Seb ; 58(2): 116-9, 2005 Apr.
Article in Hungarian | MEDLINE | ID: mdl-16018279

ABSTRACT

The aim of this study was to develop a new method to check of the viability of an extraabdominally transplanted omental flap. We performed free omental transplantation to the left lateral neck region in the frame of a formerly published new esophageal resection series on 5 dogs. Intraoperative laser Doppler flowmetry was performed, before and after isolation, after transplantation, and 14 days after the operation. From the 5 transplanted flaps, 4 survived the transplantation. The flap microcirculation deteriorated immediately after the transplantation, but at the time of re-operation the measurements showed similar microcirculation as control tissues, which proves the viability of the transplanted flaps. In our opinion, in dogs for the intraoperative monitoring of viability and microcirculation of free transplanted omental flaps, laser Doppler flowmetry is a feasible method.


Subject(s)
Intraoperative Care/methods , Laser-Doppler Flowmetry , Microcirculation , Omentum/blood supply , Omentum/transplantation , Surgical Flaps , Animals , Dogs , Graft Survival , In Vitro Techniques
14.
Am Surg ; 70(11): 1019-24, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15586519

ABSTRACT

After a positive sentinel lymph node (SLN) biopsy, some patients may be considered to have a very low risk of non-SLN involvement and could be candidates for axillary sparing. The aim of this study was to validate the nomogram created at the Memorial Sloan-Kettering Cancer Center (MSKCC) for the prediction of non-SLN involvement in an independent set of 140 patients with both positive SLNs and axillary dissection. The predicted proportions of positive non-SLNs were compared with the observed percentages of non-SLN metastasis. Although the SLN metastasis size and tumor size did influence the risk of non-SLN involvement, the correlation between the predicted and observed proportions was weaker for our patients (R: 0.84) than for the patients assessed at the MSKCC (R: 0.97). Differences were noted in the intraoperative assessment and in the final histology of the SLNs (imprints vs frozen sections and more detailed vs less detailed, respectively), and these could partly explain the lower level of the correlation. The nomogram could not be validated and was found to be of only limited use for the prediction of non-SLN involvement in patients operated on under similar, though not fully identical conditions. We therefore warn against the unvalidated use of this prediction tool.


Subject(s)
Breast Neoplasms/pathology , Lymphatic Metastasis , Nomograms , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis/diagnosis
15.
Jpn J Clin Oncol ; 34(9): 519-24, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15466825

ABSTRACT

BACKGROUND: After completion of axillary dissection, many breast cancer patients with axillary sentinel nodal involvement are found to have regional disease limited to the sentinel nodes. These patients are exposed to the morbidity of axillary clearance without any expected therapeutic benefit. METHODS: Sentinel node biopsy was performed either with Patent blue dye or with a combined dye, radiocolloid and gamma-probe-guided method involving peritumoral tracer administration. For a series of 150 consecutive patients with involved axillary sentinel nodes and axillary dissection, factors associated with non-sentinel nodal involvement were analysed in a multivariate analysis based on logistic regression with the use of fractional polynomials. RESULTS: The following variables were found to be potentially associated with non-sentinel node metastases: tumour size, sentinel node metastasis size, number of examined sentinel nodes, percentage of involved sentinel nodes (the latter two were found to be significant only when in combination), and extracapsular perinodal spread. CONCLUSIONS: Isolated tumour cells and micrometastases in axillary sentinel nodes carry a low risk of non-sentinel node metastasis. The risk of metastasis to further echelon nodes is higher with macrometastases, especially if there is extracapsular growth and the proportion of involved sentinel nodes is high.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Lymph Node Excision , Lymph Nodes/pathology , Sentinel Lymph Node Biopsy , Axilla , Female , Humans , Lymphatic Metastasis , Multivariate Analysis , Neoplasm Staging
16.
Microsurgery ; 23(5): 414-8, 2003.
Article in English | MEDLINE | ID: mdl-14557993

ABSTRACT

Our objective was the elaboration of a new animal model for the free transplantation of an omental flap and the examination of its viability in dogs. The cooled omental flap from the abdomen was freely transplanted to the lateral cervical region, and its blood supply was established with microsurgical anastomoses. The technique was developed in 5 dogs, and short-term survival examinations were later carried out in 3 cases by means of this method. Postoperative viability was assessed by angiography, methylene blue testing, and histology. Of the 3 transplanted grafts, 2 still survived 1 week after the operation. For technical reasons, 1 flap thrombotized. For determination of the viability of the transplanted graft, histology proved best. Vital reactions, including granulation tissue and angiogenesis, were present on the histological slides. The short-term survival of an omental flap can be ensured with microsurgical transplantation in dogs.


Subject(s)
Microsurgery/methods , Omentum/transplantation , Tissue Transplantation/methods , Anastomosis, Surgical , Animals , Dogs , Models, Animal , Omentum/blood supply
17.
World J Surg ; 26(5): 592-7, 2002 May.
Article in English | MEDLINE | ID: mdl-12098052

ABSTRACT

The optimal technique for sentinel lymph node biopsy (SLNB) is still debated. SLNB with peritumoral injection of Patent blue dye was performed in 129 clinically T1-T2 and N0 breast cancers in 127 patients (group A); it was later replaced by combined dye and radiocolloid-guided SLNB preceded by lymphoscintigraphy in 72 breast cancer patients (group B). This study compares these two methods. All patients underwent completion axillary dissection. Means of 1.4 and 1.3 SLNs were identified in groups A and B, respectively. The mean number of non-SLNs for the whole series was 14.9 (range 5-42). The first 53 cases of lymphatic mapping (dye only) comprised the institutional learning period during which the identification rate of at least 1 SLN in 30 consecutive attempts reached 90%. The identification rate for the subsequent 76 group A patients was 92%. The accuracy rate of SLNBs for overall axillary nodal status prediction and the false-negative rate for group A patients (after excluding the learning-phase cases) were 93% and 10%, respectively. All 72 group B cases had at least one SLN identified, and only one false-negative case occurred in this group (accuracy and false-negative rates of 99% and 3%, respectively). Both the dye-only and the combined SLNB methods are suitable for SLN identification, but the latter works better and results in higher accuracy, a higher negative predictive value, and a lower false-negative rate. It is therefore the method of choice.


Subject(s)
Breast Neoplasms/pathology , Coloring Agents , Lymph Nodes/pathology , Sentinel Lymph Node Biopsy/methods , Breast Neoplasms/diagnostic imaging , Female , Humans , Lymph Nodes/diagnostic imaging , Middle Aged , Radionuclide Imaging , Sensitivity and Specificity
18.
Orv Hetil ; 143(9): 437-46, 2002 Mar 03.
Article in Hungarian | MEDLINE | ID: mdl-12013684

ABSTRACT

INTRODUCTION: The optimal technique of sentinel node biopsy (SNB) is still debated. AIMS: To compare two methods of SNB, describe the learning phase, the validation of the methods and the first results after implementing SNB as standard of care in selected breast cancer patients. PATIENTS AND METHODS: SNB with peritumoral or intratumoral injection of Patent blue dye only was performed in 129 clinically T1-T2 and N0 breast cancers in 127 patients (Group A); it was later replaced by combined dye and radiocolloid-guided SNB preceded by lymphoscintigraphy in 72 breast cancer patients (Group B). All patients underwent completion axillary dissection. Group C, to date, comprises 50 patients, in whom axillary dissection was performed on the basis of the SNB. Intraoperative imprint cytology was performed, and whenever positive, the axillary dissection was completed in the same step, whereas in cases of negative cytology findings but positive final histology, the dissection was done as a second operation. Histopathological assessment of SNs involved step sectioning and immunohistochemistry. RESULTS: Means of 1.4 and 1.3 SNs were identified in Groups A and B, respectively. The mean number of non-SNs for the whole series was 14.7 (range 5-42). The first 53 cases of lymphatic mapping with patent blue dye comprised the institutional learning period, during which the identification rate of at least 1 SN in 30 consecutive attempts reached 90%. The identification rate for the subsequent 76 Group A patients was 92%. The accuracy of SNB for overall axillary nodal status prediction and the false-negative rate for Group A patients (after exclusion of the learning-phase cases) were 93% and 10%, respectively. All 72 Group B cases had at least 1 SN identified, and only 1 false-negative case occurred in this group, i.e. the accuracy and false-negative rate were 99% and 3%, respectively. The identification rate in Group C was 98%; axillary dissection could be avoided in 25 patients, it was performed at the same time as the SNB in 15 and as a second operation in 10. Till now, no axillary recurrence was detected in Group C patients, although the follow-up period is short for the moment. CONCLUSIONS: The dye only and the radioguided SNB methods are complementary, their combination improves the performance, and can be the basis of performing axillary dissection on the basis of SNB results. After the technique of SNB has been validated in a given institution, it can become standard of care in a well selected group of patients, but requires a close follow up.


Subject(s)
Breast Neoplasms/pathology , Education, Medical, Continuing/statistics & numerical data , Learning , Sentinel Lymph Node Biopsy , Adult , Aged , Axilla , Breast Neoplasms/surgery , Female , Hospitals, County , Humans , Hungary , Lymph Node Excision , Middle Aged , Sentinel Lymph Node Biopsy/education , Sentinel Lymph Node Biopsy/methods , Sentinel Lymph Node Biopsy/standards
19.
Magy Seb ; 55(6): 375-7, 2002 Dec.
Article in Hungarian | MEDLINE | ID: mdl-12616823

ABSTRACT

UNLABELLED: Sentinel lymph node mapping has already been accepted as part of the treatment for malignant melanomas of the skin and in breast carcinomas. The status of lymph nodes is an important prognostic marker in colorectal carcinoma as well. The authors tried the feasibility of this technique in colorectal carcinomas. The technique is analogous to the one used in breast cancer and melanoma: 2 ml of 2.5% Patentblau dye was given subserosally around the tumor. After resection the specimen was immediately sent to pathology where the lymph nodes were removed. This technique has been tried on 31 patients, 22 with colonic and 9 with rectal tumors. Of these patients, 15 were Dukes stage C, 14 were Dukes stage B and 2 were Dukes stage A. An average 4.3 blue lymph nodes were found in colon tumors and 5.4 in rectal tumors and an average 14 unstained lymph nodes were found in colon tumors, and 7 in rectal tumors. The blue nodes were predictive of the nodal status in 9 of the 15 Dukes stage C patients. In these cases the blue lymph nodes contained metastases and there were 2 cases where metastases were limited to the blue lymph nodes. SUMMARY: The authors found a high false negative rate for lymphatic mapping with the vital dye technique, therefore they try to change the method according to that used by Saha et al. The aim of sentinel node identification in colorectal carcinomas would be improved staging rather than reducing of the extent of lymphadenectomy. The role of lymphatic mapping in large bowel cancers needs further investigations. Until the results are reliable, as many lymph nodes as possible have to be excited and sent for histology.


Subject(s)
Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Sentinel Lymph Node Biopsy , Aged , Coloring Agents , False Negative Reactions , Female , Humans , Lymph Node Excision , Lymphatic Metastasis , Male , Neoplasm Staging , Rosaniline Dyes
SELECTION OF CITATIONS
SEARCH DETAIL
...